organophosphonates has been researched along with galidesivir in 4 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (galidesivir) | Trials (galidesivir) | Recent Studies (post-2010) (galidesivir) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 46 | 1 | 40 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, AW; Neuendorff, DA; Randel, RD; Weems, CW; Weems, YS | 1 |
| Burgos, ES; Kamat, SS; Raushel, FM | 1 |
| Bavari, S; Cardile, AP; Mayers, DL | 1 |
| Bekerman, E; Einav, S | 1 |
1 review(s) available for organophosphonates and galidesivir
| Article | Year |
|---|---|
Current status of chemically synthesized inhibitors of Ebola virus.
Topics: Adenine; Adenosine; Amides; Antiviral Agents; Cytosine; Drug Discovery; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Patents as Topic; Purine Nucleosides; Pyrazines; Pyrrolidines | 2014 |
3 other study(ies) available for organophosphonates and galidesivir
| Article | Year |
|---|---|
Endocannabinoid 1 and 2 (CB(1); CB(2)) receptor agonists affect negatively cow luteal function in vitro.
Topics: Adenine; Adenosine; Animals; Arachidonic Acids; Cattle; Corpus Luteum; Dinoprost; Dinoprostone; Female; In Vitro Techniques; Indoles; Organophosphonates; Piperidines; Pregnancy; Progesterone; Pyrazoles; Pyrrolidines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |
Potent inhibition of the C-P lyase nucleosidase PhnI by Immucillin-A triphosphate.
Topics: Adenine; Adenosine; Adenosine Triphosphate; Catalysis; Escherichia coli; Escherichia coli Proteins; Lyases; Magnesium; Models, Chemical; Organophosphonates; Pentosephosphates; Polyphosphates; Pyrrolidines | 2013 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |